See All Slides -

Slides

Presentation JIM 2020

PCI in a NSTEMI patient When less is more…

Presenter: Baralis Giorgio

February 13, 2020

Presentation JIM 2020

Optimized DES for High ischemic risk & HBR patients: when efficacy and safety converge into one need

Presenter: Marco Valgimigli

February 13, 2020

Presentation JIM 2020

The Abluminus DES+: from the technical features to the clinical program

Presenter: Luca Testa

February 13, 2020

Presentation JIM 2020

Meeting the changing needs of TAVI patients - importance of hemodynamics and avoiding patient prosthesis mismatch

Presenter: Flavio Ribichini

February 13, 2020

Presentation JIM 2020

When to pre and post dilate a TAVI

Presenter: Federico De Marco

February 13, 2020

Presentation JIM 2020

Supraflex Cruz in the challenging scenario of older MI patients

Presenter: Gianluca Campo

February 13, 2020

Presentation JIM 2020

Present and future of resorbable magnesium scaffold. An expert review.

Presenter: Stefano Galli

February 13, 2020

Presentation JIM 2020

Drug-coated balloon vs. drug eluting stent for small coronary vessel disease: 6-mo. primary outcome of the PICCOLETO II randomized clinical trial.

Presenter: Bernardo Cortese

February 13, 2020

Presentation

“Is Sirolimus the new concept for Drug Coated Balloon?”

Presenter: Bernardo Cortese

February 13, 2020

Presentation JIM 2020

Innovations in PCI: Update in Drug Coated Balloon Technologies(Focus on Paclitaxel Toxicity)

Presenter: Juan Granada

February 13, 2020

Advertisement

Slides

PCI in a NSTEMI patient When less is more…

Optimized DES for High ischemic risk & HBR patients: when efficacy and safety converge into one need

The Abluminus DES+: from the technical features to the clinical program

Meeting the changing needs of TAVI patients - importance of hemodynamics and avoiding patient prosthesis mismatch

When to pre and post dilate a TAVI

Supraflex Cruz in the challenging scenario of older MI patients

Present and future of resorbable magnesium scaffold. An expert review.

Drug-coated balloon vs. drug eluting stent for small coronary vessel disease: 6-mo. primary outcome of the PICCOLETO II randomized clinical trial.

“Is Sirolimus the new concept for Drug Coated Balloon?”

Innovations in PCI: Update in Drug Coated Balloon Technologies(Focus on Paclitaxel Toxicity)

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content